Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 8/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 2months HR therapy.

Abundance in Group 1: increased abundance in TB +HRZ group - 2months into HR therapy(W12)

NCBI	Quality Control	Links
Akkermansia
Barnesiella
Prolixibacter
Lachnospiraceae
Desulfovibrio
Bifidobacterium
Anaerorhabdus
Flavonifractor
Parasutterella
Anaerosporobacter
Paraprevotella
Acetatifactor
Mucispirillum
Intestinimonas
Parvibacter
Olsenella
Hydrogenoanaerobacterium
Eisenbergiella

Revision editor(s): KateRasheed